Jonathan D. Kaunitz & Meghan Keeffe
doi : 10.1007/s10620-020-06365-5
Digestive Diseases and Sciences volume 66, pages1375–1379(2021)
Petr Vanek, Guru Trikudanathan & Martin L. Freeman
doi : 10.1007/s10620-020-06413-0
Digestive Diseases and Sciences volume 66, pages1380–1382(2021)
Amol Agarwal & Paul J. Thuluvath
doi : 10.1007/s10620-020-06422-z
Digestive Diseases and Sciences volume 66, pages1383–1385(2021)
A. Palermo, A. Gerussi, G. Mulinacci, P. Invernizzi & M. Carbone
doi : 10.1007/s10620-020-06402-3
Digestive Diseases and Sciences volume 66, pages1386–1387(2021)
Alex Straumann & Thomas Greuter
doi : 10.1007/s10620-020-06451-8
Digestive Diseases and Sciences volume 66, pages1388–1389(2021)
Robert N. Lopez & Andrew S. Day
doi : 10.1007/s10620-020-06427-8
Digestive Diseases and Sciences volume 66, pages1390–1391(2021)
Jana G. Hashash & Fadi H. Mourad
doi : 10.1007/s10620-020-06402-3
Digestive Diseases and Sciences volume 66, pages1386–1387(2021)
Shiva Kumar
doi : 10.1007/s10620-021-06854-1
Digestive Diseases and Sciences volume 66, pages1394–1399(2021)
Zhi-Feng Jiang & Lin Zhang
doi : 10.1007/s10620-020-06417-w
Digestive Diseases and Sciences volume 66, pages1400–1408(2021)
Long non-coding RNAs (lncRNAs) are transcripts longer than 200 nucleotides and play important roles in a variety of diseases. LncRNAs are involved in many biologic processes including cell differentiation, development, and apoptosis. The intestinal barrier is considered one of the most important protective barriers in humans. Severe damage or dysfunction of the intestinal barrier may be associated with the occurrence and development of many diseases, such as inflammatory bowel disease and ulcerative colitis. LncRNAs have been found to be associated with intestinal barrier function in some studies, which are at an early stage. In this review, we introduce the roles of LncRNAs in the intestinal barrier and investigate the possibility of lncRNAs as a research field in the intestinal barrier.
Georgina R. Jones & Mark P. Molloy
doi : 10.1007/s10620-020-06390-4
Digestive Diseases and Sciences volume 66, pages1409–1414(2021)
Hester C. Timmerhuis, Sven M. van Dijk, Robert C. Verdonk, Thomas L. Bollen, Marco J. Bruno, Paul Fockens, Jeanin E. van Hooft, Rogier P. Voermans, Marc G. Besselink & Hjalmar C. van Santvoort for the Dutch Pancreatitis Study Group
doi : 10.1007/s10620-020-06413-0
Digestive Diseases and Sciences volume 66, pages1415–1424(2021)
Severe pancreatitis may result in a disrupted pancreatic duct, which is associated with a complicated clinical course. Diagnosis of a disrupted pancreatic duct is not standardized in clinical practice or international guidelines. We performed a systematic review of the literature on imaging modalities for diagnosing a disrupted pancreatic duct in patients with acute pancreatitis.
Zain A. Sobani, Christina Ling & Tarun Rustagi
doi : 10.1007/s10620-020-06422-z
Digestive Diseases and Sciences volume 66, pages1425–1435(2021)
The mainstay of management of acute cholecystitis has been surgical, with percutaneous gallbladder drainage in patients deemed high risk for surgical intervention. Endoscopic management of acute cholecytitis with transpapillary and transmural drainage of the gall bladder is emerging as a viable alternative in high-risk surgical patients. In this article, we discuss the background, current status, technical challenges and strategies to overcome them, adverse events, and outcomes of endoscopic transpapillary gallbladder drainage for management of acute cholecystitis.
M. Zanni, S. Vaccari, A. Lauro, I. R. Marino, M. Cervellera, V. D’Andrea & V. Tonini
doi : 10.1007/s10620-021-06849-y
Digestive Diseases and Sciences volume 66, pages1436–1440(2021)
Adenocarcinoma as the primary cause of bowel intussusception is uncommon. We describe the case of a 86-year-old patient admitted for ileocecal intussusception due to the presence of adenocarcinoma, located in the ileocecal valve and right colon. The etiologies of intussusception, its diagnosis, and conservative or surgical treatments are discussed, with attention placed on the indications for reduction of the invagination prior to surgical resection.
Manuel Zanni
doi : 10.1007/s10620-021-06850-5
Digestive Diseases and Sciences volume 66, page1441(2021)
George Triadafilopoulos & Charles Lombard
doi : 10.1007/s10620-020-06605-8
Digestive Diseases and Sciences volume 66, pages1442–1445(2021)
Connie W. Wang, Adrienne Lebsack, Rebecca L. Sudore & Jennifer C. Lai
doi : 10.1007/s10620-020-06369-1
Digestive Diseases and Sciences volume 66, pages1446–1451(2021)
Patients with end-stage liver disease awaiting liver transplantation (LT) are seriously ill and experience fluctuating periods of clinical decompensation. Discussion of a patient’s advance care planning (ACP) wishes early in their dynamic disease course is critical to providing value-aligned care while awaiting LT. We aimed to evaluate current ACP documentation and assess readiness to engage in ACP in this population.
Christopher J. Danford, Jennifer Y. Lee, Ian A. Strohbehn, Kathleen E. Corey & Michelle Lai
doi : 10.1007/s10620-020-06388-y
Digestive Diseases and Sciences volume 66, pages1452–1460(2021)
Current genetic research of nonalcoholic steatohepatitis (NASH) cirrhosis is limited by our ability to accurately identify cases on a large scale. Our objective was to develop and validate an electronic health record (EHR) algorithm to accurately identify cases of NASH cirrhosis in the EHR.
Adeyinka Charles Adejumo, Daud H. Akhtar, Brittany B. Dennis, George Cholankeril, Quazim Alayo, Olumuyiwa A. Ogundipe, Donghee Kim & Aijaz Ahmed
doi : 10.1007/s10620-020-06402-3
Digestive Diseases and Sciences volume 66, pages1461–1476(2021)
The prevalence, characteristics, burden and trends of primary biliary cholangitis (PBC) hospitalizations in the USA remain unclear.
Johannes P. D. Schultheiss, Sandra Altena, Max R. Clevers, Dominique Baas, Bindia Jharap & Herma H. Fidder
doi : 10.1007/s10620-020-06395-z
Adherence to adalimumab in inflammatory bowel disease (IBD) patients is reported to be below par. Non-adherence may result in loss-of-response and increased hospitalization. We analyzed the effect of an electronic needle container (ENC) on adherence to adalimumab.
Ying Cui, Jun Zhang, Yan Chen & Le-gao Chen
doi : 10.1007/s10620-020-06350-y
Digestive Diseases and Sciences volume 66, pages1488–1498(2021)
Heparanase (HPSE) is considered to play an important role in the occurrence, development and carcinogenesis of ulcerative colitis (UC). There are no reports about the detection of HPSE mRNA in feces to predict UC activity and cancerization risk.
Deliang Yu & Chi Zhang
doi : 10.1007/s10620-020-06358-4
Digestive Diseases and Sciences volume 66, pages1499–1509(2021)
Gastric carcinoma (GC) is one of the most common malignant tumors. Although increasing studies have indicated that circular RNAs function as ideal biomarkers for multiple cancers, only a few researches elucidated the correlation between circular RNA PTK2 (circPTK2) and human cancers.
Panagiota Chadla, Marina Arbi, Sofia Nikou, Theodoros Kalliakoudas, Helen Papadaki, Stavros Taraviras, Zoi Lygerou & Vasiliki Bravou
doi : 10.1007/s10620-020-06364-6
Digestive Diseases and Sciences volume 66, pages1510–1523(2021)
Genomic instability is a hallmark of cancer cells contributing to tumor development and progression. Integrin-linked kinase (ILK) is a focal adhesion protein with well-established role in carcinogenesis. We have previously shown that ILK overexpression is critically implicated in human colorectal cancer (CRC) progression. In light of the recent findings that ILK regulates centrosomes and mitotic spindle formation, we aimed to determine its implication in mechanisms of genomic instability in human CRC.
Yajuan Cao, Qingsong Tao, Xiaoming Kao & Xinhua Zhu
doi : 10.1007/s10620-020-06416-x
Digestive Diseases and Sciences volume 66, pages1524–1532(2021)
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death in the worldwide. A great number of reports manifested that circular RNA hsa-circRNA-103809 (circRNA-103809) could work in several cancers.
Jing Liao, Fei Ding, Wei Luo, Xin Nie, Yong He & Guixing Li
doi : 10.1007/s10620-020-06379-z
Digestive Diseases and Sciences volume 66, pages1533–1539(2021)
Insulinoma, owing to the low incidence and small volume of the tumor, is often undiagnosed. The 72-h fast test is centered on diagnosing insulinoma; however, it cannot be performed on outpatients. Our aim was to evaluate the results of a 3-h oral glucose tolerance test (3-h OGTT) for insulinoma diagnosis.
Yousuke Nakai, Hiroki Oyama, Sachiko Kanai, Kensaku Noguchi, Tatsuya Sato, Ryunosuke Hakuta, Kazunaga Ishigaki, Kei Saito, Tomotaka Saito, Tsuyoshi Hamada, Naminatsu Takahara, Suguru Mizuno, Hirofumi Kogure, Hiroyuki Isayama & Kazuhiko Koike
doi : 10.1007/s10620-020-06345-9
Digestive Diseases and Sciences volume 66, pages1540–1547(2021)
Endoscopic ultrasonography (EUS)-guided interventions are often performed using a single guidewire (SGW), but there are a few reports on the use of double guidewire (DGW) technique to facilitate multiple drainage placement during EUS-guided drainage of pancreatic fluid collections. This DGW technique may have advantages other than multiple drainage placement during EUS-guided interventions such as scope stabilization, support for stone extraction and device insertion.
Kiyoaki Yabe, Akira Horiuchi, Takahiro Kudo, Ichitaro Horiuchi, Yasuyuki Ichise, Masashi Kajiyama & Naoki Tanaka
doi : 10.1007/s10620-020-06393-1
Digestive Diseases and Sciences volume 66, pages1548–1555(2021)
Prospective studies on bleeding risk during/after gastrointestinal endoscopic procedures are rare.
Christine Lingblom, Sofie Albinsson, Leif Johansson, Helen Larsson & Christine Wenner?s
doi : 10.1007/s10620-020-06368-2
Digestive Diseases and Sciences volume 66, pages1556–1564(2021)
Noninvasive methods to assess treatment response in eosinophilic esophagitis are needed.
Cesare Tosetti, Edoardo Savarino, Edoardo Benedetto, Rudi De Bastiani on behalf of the Study Group for the Evaluation of GERD Triggering Foods
doi : 10.1007/s10620-020-06414-z
Digestive Diseases and Sciences volume 66, pages1565–1571(2021)
The relationship between aliments and pathophysiological abnormalities leading to gastroesophageal reflux disease (GERD) symptoms elicitation is unclear. Nevertheless, patients often report symptoms after ingestion of specific foods.
Mendel E. Singer & Michael S. Smith
doi : 10.1007/s10620-020-06412-1
Digestive Diseases and Sciences volume 66, pages1572–1579(2021)
Wide area transepithelial sampling with three-dimensional computer-assisted analysis (WATS3D) is an adjunct to the standard random 4-quadrant forceps biopsies (FB, “Seattle protocol”) that significantly increases the detection of Barrett’s esophagus (BE) and associated neoplasia in patients undergoing screening or surveillance.
Chanakyaram A. Reddy, Anna Tavakkoli, Vincent L. Chen, Sheryl Korsnes, Aarti Oza Bedi, Philip W. Carrott, Andrew C. Chang, Kiran H. Lagisetty, Richard S. Kwon, B. Joseph Elmunzer, Mark B. Orringer, Cyrus Piraka, Anoop Prabhu, Rishindra M. Reddy, Erik Wamsteker & Joel H. Rubenstein
doi : 10.1007/s10620-020-06377-1
Digestive Diseases and Sciences volume 66, pages1580–1587(2021)
Endoscopic therapy (ET) and esophagectomy result in similar survival for Barrett’s esophagus (BE) with high-grade dysplasia (HGD) or T1a esophageal adenocarcinoma (EAC), but the long-term quality of life (QOL) has not been compared.
Kevin O. Turner, Robert M. Genta & Amnon Sonnenberg
doi : 10.1007/s10620-020-06357-5
Digestive Diseases and Sciences volume 66, pages1588–1592(2021)
The causes for the occurrence of goblet cells at the gastroesophageal junction (GEJ-GC) are unknown. The aim of our study was to compare the concurrent histologic changes of the stomach in (1) patients with GEJ-GC, but without Barrett’s esophagus (BE) to those in (2) patients with BE and in (3) controls without GEJ-GC or BE.
Daniel J. Stein, Matthew B. Moore, Gila Hoffman & Joseph D. Feuerstein
doi : 10.1007/s10620-020-06396-y
Digestive Diseases and Sciences volume 66, pages1593–1599(2021)
Percutaneous gastrostomy (PEG) is a common inpatient procedure. Prior data from National Inpatient Sample (NIS) in 2006 reported a mortality rate of 10.8% and recommended more careful selection of PEG candidates. This study assessed for improvement in the last 10 years in mortality rate and complications for hospitalized patients.
Mimi C. Tan, Niharika Mallepally, Quynh Ho, Yan Liu, Hashem B. El-Serag & Aaron P. Thrift
doi : 10.1007/s10620-020-06399-9
Digestive Diseases and Sciences volume 66, pages1600–1610(2021)
Studies on diet and gastric intestinal metaplasia (GIM) risk are lacking in US populations.
James Y. Han, Zain Moosvi, Erica Duh, Sunhee Park, Gregory C. Albers, Jason B. Samarasena & William Karnes
doi : 10.1007/s10620-020-06383-3
Digestive Diseases and Sciences volume 66, pages1611–1619(2021)
Peppermint oil is well known to inhibit smooth muscle contractions, and its topical administration during colonoscopy is reported to reduce colonic spasms.
Abhi K. Singh, Rajender Kumar, Pankaj Gupta, Praveen Kumar-M, Shubhra Mishra, Harshal S. Mandavdhare, Harjeet Singh, Kaushal K. Prasad, Usha Dutta & Vishal Sharma
doi : 10.1007/s10620-020-06361-9
Digestive Diseases and Sciences volume 66, pages1620–1630(2021)
Ileocecal thickening (ICT) on imaging could result from diverse etiologies but may also be clinically insignificant.
Vineet S. Rolston, Jessica Kimmel, Violeta Popov, Brian P. Bosworth, David Hudesman, Lisa B. Malter, Simon Hong & Shannon Chang
doi : 10.1007/s10620-020-06344-w
Digestive Diseases and Sciences volume 66, pages1631–1638(2021)
Ustekinumab (UST) is a monoclonal antibody inhibitor of IL-12/IL-23 approved for the treatment of Crohn’s disease (CD) and ulcerative colitis (UC). We conducted a meta-analysis to compare rates of adverse events (AEs) in randomized controlled trials (RCTs) of UST for all indications.
Parul Tandon, Eugenia Y. Lee, Cynthia Maxwell, Lara Hitz, Lindsy Ambrosio, Levinus Dieleman, Brendan Halloran, Karen Kroeker & Vivian M. Huang
doi : 10.1007/s10620-020-06381-5
Digestive Diseases and Sciences volume 66, pages1639–1649(2021)
The role of fecal calprotectin in predicting pregnancy-related outcomes in inflammatory bowel disease (IBD) remains unknown.
Bhairavi Balram, Joshua Lubov, Yves Theoret, Waqqas Afif, Alain Bitton, Gary Wild, Peter L. Lakatos & Talat Bessissow
doi : 10.1007/s10620-020-06427-8
Digestive Diseases and Sciences volume 66, pages1650–1657(2021)
Immunomodulator monotherapy is an important component in the treatment of inflammatory bowel disease (IBD). However, there is conflicting literature about thiopurines maintaining long-term remission in patients with active IBD.
Mingming Zhu, Xitao Xu, Qi Feng, Zhe Cui, Tianrong Wang, Yunqi Yan & Zhihua Ran
doi : 10.1007/s10620-020-06398-w
Digestive Diseases and Sciences volume 66, pages1658–1668(2021)
Information concerning deep radiological healing of perianal fistulas in Chinese patients with CD is limited. The present study aimed to establish the effectiveness of infliximab on CD-related perianal fistulas using magnetic resonance imaging (MRI) and identify predictors of deep radiological remission of fistulas.
Zhensheng Wang, Hashem B. El-Serag & Aaron P. Thrift
doi : 10.1007/s10620-020-06397-x
Digestive Diseases and Sciences volume 66, pages1669–1672(2021)
Recent findings indicate a shift in the epidemiology of non-cardia gastric cancer in the USA. In particular, an uprising trend in incidence rates among non-Hispanic whites aged <?50 years.
Zhen-Feng Wu, Kun Zou, Guan-Nan Wu, Zhao-Jia Jin, Chun-Jie Xiang, Shuo Xu, Yao-Hui Wang, Xiao-Yu Wu, Che Chen, Zhe Xu, Wei-Su Li, Xue-Quan Yao, Jun-Feng Zhang & Fu-Kun Liu
doi : 10.1007/s10620-020-06415-y
Digestive Diseases and Sciences volume 66, pages1673–1682(2021)
How gastric cancer (GC) incidence is associated with changes in the gastric microbiome has not been firmly established. The present study therefore aims to investigate the microbial communities present within the gastric mucosa of patients with superficial gastritis (SG) or GC.
Hedong Han, Wei Guo, Honglei Guo, Xin Wei, Xiaochun Xiao, Yiming Ruan, Cheng Wu, Yang Cao & Jia He
doi : 10.1007/s10620-020-06355-7
Digestive Diseases and Sciences volume 66, pages1683–1692(2021)
Compared to general population, human immunodeficiency virus (HIV) infection may increase frequency of acute pancreatitis (AP); however, evidence regarding effects of HIV infection on AP-related outcomes is limited and controversial.
Rachel Shireen Golpanian, Gil Yosipovitch & Cynthia Levy
doi : 10.1007/s10620-020-06392-2
Digestive Diseases and Sciences volume 66, pages1693–1699(2021)
Pruritus is a debilitating symptom of cholestatic diseases such as primary biliary cholangitis and primary sclerosing cholangitis and often results in major reduction in quality of life for afflicted patients. Classic treatment options for the treatment of cholestatic pruritus include antihistamines, bile acid resins, serotonin reuptake inhibitors, and mu-opioid antagonists. Unfortunately, these drugs are not always successful in treating pruritus of cholestasis and may be associated with adverse effects. Recent advances in our understanding of itch pathophysiology have led to the use of butorphanol, a kappa-opioid agonist and mu-opioid antagonist, for the treatment of various forms of pruritus. Reports of butorphanol to treat cholestatic itch specifically are rare.
Rintaro Hashimoto, David P. Lee, Jason B. Samarasena, Vishal S. Chandan, Wenchang Guo, John G. Lee & Kenneth J. Chang
doi : 10.1007/s10620-020-06391-3
Digestive Diseases and Sciences volume 66, pages1700–1706(2021)
EUS-guided liver biopsy (EUS-LB) has been shown to be a safe and effective alternative to percutaneous liver biopsy. The optimal needle device and technique for EUS-LB is still evolving. The aim of this study was to compare the efficacy of two second-generation 19G fine-needle biopsy (FNB) (Franseen- and Fork-tip) devices for EUS-LB.
Sahil D. Doshi, Matthew J. Stotts, Rebecca A. Hubbard & David S. Goldberg
doi : 10.1007/s10620-020-06346-8
Digestive Diseases and Sciences volume 66, pages1707–1714(2021)
Alcoholic hepatitis is a major cause of morbidity and mortality. However, there are limited population-based data on its incidence, demographics, and temporal trends. We performed a retrospective cohort study using the State Inpatient Databases from Florida, Massachusetts, New York, and Washington from 2010 to 2014. We included patients aged 20–79 years admitted with alcoholic hepatitis and calculated incidence using population denominators obtained from the Centers for Disease Control and Prevention WONDER database. We fit multivariable Poisson regression models to explore interactions between alcoholic hepatitis incidence rates and several predictors including state, calendar year, age, race/ethnicity, and gender. Among 56,973 unique individuals with alcoholic hepatitis, the majority were male (39,702; 69.7%) and white non-Hispanic (40,934; 72.0%). In multivariable Poisson models, there was a significant interaction between calendar year and age group (p?<?0.001), with the highest incidence rates in those ages 40–49 and 50–59 across all years. The absolute increase in incidence rate across calendar years was highest in the 20–29 and 30–39 age groups in every state. Female gender was associated with a lower rate (incidence rate ratio (IRR) 0.42, 95% confidence interval (CI) 0.41–0.42, p?<?0.001). Compared to white non-Hispanics, black non-Hispanics (IRR 0.79, CI 0.77–0.81, p?<?0.001) and Hispanics (0.66, CI 0.65–0.68, p?<?0.001) had lower incidence rates. The incidence of alcoholic hepatitis in the USA varies by age, gender, race/ethnicity, and state of residence. The group with the fastest rising incidence is those aged 20–39. More work is needed to evaluate the reasons for the temporal trends for admissions for alcoholic hepatitis.
Bridgette B. McNally & Elizabeth J. Carey
doi : 10.1007/s10620-020-06347-7
Digestive Diseases and Sciences volume 66, pages1715–1719(2021)
Standard of care treatment for AIH includes prednisone monotherapy or dual therapy prednisone–azathioprine. However, many hepatologists alternatively use azathioprine monotherapy to avoid side effects of long-term corticosteroids.
Tadashi Kegasawa, Ryotaro Sakamori, Kazuki Maesaka, Ryoko Yamada, Yuki Tahata, Ayako Urabe, Takahiro Kodama, Hayato Hikita, Kazuho Imanaka, Kazuyoshi Ohkawa, Naoki Hiramatsu, Masahide Oshita, Yukinori Yamada, Masami Inada, Takayuki Yakushijin, Yasuharu Imai, Tomohide Tatsumi & Tetsuo Takehara
doi : 10.1007/s10620-020-06380-6
Digestive Diseases and Sciences volume 66, pages1720–1729(2021)
Although the serum sodium level has been reported to be a prognostic and predictive marker for the therapeutic effects of lung cancer and renal cell carcinoma treated with molecular targeted therapy, the serum sodium level has not been investigated in hepatocellular carcinoma (HCC) patients treated with sorafenib. The aim of our analysis was to assess the prognostic role of serum sodium levels in these patients.
Shu-Yein Ho, Chia-Yang Hsu, Po-Hong Liu, Rheun-Chuan Lee, Chih-Chieh Ko, Yi-Hsiang Huang, Chien-Wei Su, Ming-Chih Hou & Teh-Ia Huo
doi : 10.1007/s10620-020-06384-2
Digestive Diseases and Sciences volume 66, pages1730–1738(2021)
The prognosis of patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE) is highly heterogeneous because of variable characteristics of tumor burden and liver dysfunction. We aimed to propose and validate an albumin–bilirubin (ALBI) grade-based prognostic nomogram for HCC patients undergoing TACE.
Jung Woo Shin, Joonho Jeong, Seok Won Jung, Seung Bum Lee, Bo Ryung Park, Min-Ju Kim, Eun Ji Park & Neung Hwa Park
doi : 10.1007/s10620-020-06375-3
Digestive Diseases and Sciences volume 66, pages1739–1750(2021)
Adherence to medication and maintained virologic response (MVR) are related to the risk of adverse clinical outcomes. This study aimed to compare the efficacy of entecavir (ETV) and tenofovir disoproxil fumarate (TDF) in relation to the adverse clinical outcomes among chronic hepatitis B (CHB) patients stratified according to adherence to medication and MVR.
Lan-ping Zhu, Samiullah Khan, Yang-yang Hui, Bo Yang, Sai-yu Wang, Kai-di Sun, Zi-han Yu, Jing-wen Zhao, Bang-mao Wang & Xin Chen
doi : 10.1007/s10620-020-06376-2
Digestive Diseases and Sciences volume 66, pages1751–1756(2021)
Hilal Sipahioglu & Antonio M. Esquinas
doi : 10.1007/s10620-020-06736-y
Digestive Diseases and Sciences volume 66, pages1757–1758(2021)
Sabri Selcuk Atamanalp
doi : 10.1007/s10620-020-06580-0
Digestive Diseases and Sciences volume 66, pages1759–1760(2021)
Mitchell S. Cappell
doi : 10.1007/s10620-020-06785-3
Digestive Diseases and Sciences volume 66, pages1761–1762(2021)
John A. Martin
doi : 10.1007/s10620-021-06933-3
Digestive Diseases and Sciences volume 66, pages1763–1764(2021)
Thomas L. Abell, Archana Kedar, Abigail Stocker, Karen Beatty, Lindsay McElmurray, Michael Hughes, Hani Rashed, William Kennedy, Gwen Wendelschafer-Crabb, Xiu Yang, Mostafa Fraig, Leila Gobejishvili, Endashaw Omer, Ed Miller, Michael Griswold & Christina Pinkston
doi : 10.1007/s10620-020-06374-4
Digestive Diseases and Sciences volume 66, page1765(2021)
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟